| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $721.0M | +17.3% |
| R&D Expense | $16.2M | +36.5% |
| SG&A Expense | $123.5M | +22.9% |
| Operating Income | $76.7M | +65.6% |
| Pre-tax Income | $9.0M | +131.2% |
| Income Tax | $292K | +101.5% |
| Net Income | $8.7M | +193.6% |
| EPS (Basic) | $0.07 | +200.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $168.8M | -47.4% |
| Accounts Receivable | $82.3M | +29.7% |
| Inventory | $39.8M | +37.0% |
| Current Assets | $306.2M | -27.9% |
| Total Assets | $2.95B | -7.1% |
| Current Liabilities | $141.6M | +30.1% |
| Long-term Debt | $1.47B | -7.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $344.7M | +13.8% |
| Capital Expenditures | $71.3M | +69.1% |
| Investing Cash Flow | -$121.3M | -233.3% |
| Financing Cash Flow | -$375.0M | -105.5% |
| Free Cash Flow | $273.5M | +4.9% |
| Total Liabilities |
| $1.83B |
| -3.6% |
| Stockholders' Equity | $1.13B | -12.4% |